Coinbase Closes at Record Low as Mizuho Warns on Revenue

image

(Bloomberg) — Shares of Coinbase Global Inc. closed at their lowest ever amid a broad-market tumble and a fresh warning from Mizuho Securities about the potential of a revenue miss in the first quarter.

The largest U.S. cryptocurrency trading platform fell 3.1% to $185.63 on Tuesday. After the three-day decline, shares are down nearly 50% from a November peak. The stock debuted on the Nasdaq in April.

Renewed signs of a “crypto desert,” alongside trading-fee compression, make Coinbase stock especially unattractive heading into the first half of the year, said Dan Dolev, senior fintech analyst at Mizuho, who cut his price target to $220 from $300 on the stock. With crypto prices plunging, his team is closely watching for any signs that may suggest retail investors are pulling out.

“Just from a psychological perspective, there’s the possibility that a lot of crypto investors would say I am cutting my loss” once they see Bitcoin approach their break-even point, he said.

Coinbase generates the majority of its revenue from trading fees, and its shares often almost perfectly match moves in Bitcoin. Yet, trading volumes are subdued quarter to date, and the platform continues to face pressure to reduce its fees to remain competitive, Dolev said. As a result, the bank cut its first-quarter revenue estimate for Coinbase to $1.38 billion, lower than the consensus of $1.75 billion among Wall Street analysts.

Piper Sandler analysts, led by Richard Repetto, said Coinbase’s recent pullback offers “an attractive entry point” to the growing cryptocurrency and digital asset space. Mainstream adoption of digital assets remains strong, and Coinbase is likely to be the “on ramp” for all things crypto, they wrote in a report on Tuesday.

Increasing institutional participation, however, is not a positive factor for Coinbase because they pay a fraction of the fees retail investors pay, risking a “bigger drag” on the take rate, Doley said.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More